MultiVir
is developing novel tumor suppressor and immune gene therapies for the treatment of cancer... Read moreMultiVir
is developing novel tumor suppressor and immune gene therapies for the treatment of cancer... Read more
CEO
Robert E. Sobol
News
Jul 11, 2018
The Business Journals: Tampa Bay
MultiVir: Moffitt licensing deal could provide new approach for some cancer patients
Jan 25, 2018
PharmiWeb
MultiVir: MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy
May 18, 2017
BioSpace
MultiVir: <b>MultiVir</b> Reports Gene Therapy Enhancement of Cancer Immunotherapy
May 29, 2015
HOUSTON BUSINESS JOURNAL
MultiVir: Houston life science company pulls IPO
Apr 23, 2015
SLEEKMONEY
MultiVir: MultiVir (MVIR) Plans to Raise $60 Million in May 6th IPO
Mar 31, 2015
FIERCE DRUG DELIVERY
MultiVir: Developer of viral vectors for anticancer gene therapy files for $70M IPO
Mar 30, 2015
FIERCE BIOTECH
MultiVir: Houston-based gene therapy outfit files for $70M IPO